LEADER 02502nam 2200577 450 001 9910797122503321 005 20230807215829.0 010 $a0-19-936879-1 010 $a0-19-936880-5 010 $a0-19-936878-3 035 $a(CKB)3710000000422722 035 $a(EBL)2068361 035 $a(OCoLC)910935514 035 $a(SSID)ssj0001499993 035 $a(PQKBManifestationID)12535896 035 $a(PQKBTitleCode)TC0001499993 035 $a(PQKBWorkID)11516750 035 $a(PQKB)11701228 035 $a(MiAaPQ)EBC2068361 035 $a(StDuBDS)EDZ0001192926 035 $a(Au-PeEL)EBL2068361 035 $a(CaPaEBR)ebr11064024 035 $a(CaONFJC)MIL798068 035 $a(EXLCZ)993710000000422722 100 $a20150619h20152015 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aManaging disruptive change in healthcare $elessons from a public-private partnership to advance cancer care and research /$fArnold D. Kaluzny and Donna M. O'Brien 210 1$aNew York, New York :$cOxford University Press,$d2015. 210 4$dİ2015 215 $a1 online resource (353 p.) 300 $aDescription based upon print version of record. 311 $a0-19-936877-5 320 $aIncludes bibliographical references at the end of each chapters and index. 327 $a""Acknowledgments""""Glossary of Terms and Acronyms""; ""About the Contributing Authors""; ""Name Index""; ""Subject Index"" 330 $aHealthcare faces unprecedented global challenges. Rapid advances in genomics, computational sciences, and technology -- as well as the new focus on value-based care and an increased trend toward healthcare commercialization -- represent disruptive changes to an already-fragmented delivery system. The healthcare establishment has been slow to adapt, and now faces rising cancer-care costs and lags in outcome improvement and genomically informed interventions. Managing Disruptive Change in Healthcare codifies the US National Cancer Institute's lessons from utilizing a public-private partnership w 606 $aMedical care$zUnited States 615 0$aMedical care 676 $a362.19699/4 700 $aKaluzny$b Arnold D.$01538763 702 $aO'Brien$b Donna M. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910797122503321 996 $aManaging disruptive change in healthcare$93789076 997 $aUNINA